3 novel PD-L1 post-translational modifications identified

In a recent paper, Horita H. et al. identified a set of novel Post-Translational Modifications (PTMs) of the protein Programmed Cell Death Ligand (PD-L1).

Model: Profile of PD-L1 post-translational modifications and their roles in regulating PD-L1 protein levels.

Profile of PD-L1 post-translational modifications and their roles in regulating PD-L1 protein levels. Source: Horita H. et al. (2017) – http://dx.doi.org/10.1016/j.neo.2017.02.006 (Cytoskleton Inc).

For this, a novel series of PTM enrichment assays  enabling the highly specific profiling of 4 key PTM profiles (Tyrosine phosphorylation (pY), Acetylation (Ac), Unbiquitination (Ub) and SUMOylation 2/3), have been used on EGF-stimulated A431 cell line. They revealed that EGF induced pY, Ac, mono- and poly-Ub Of PD-L1 in these EGF treated epidermoid carcinoma cells. The authors also suggested that the balance between mono- / poly-Ub of PD-L1 might regulate PD-L1 stability, as already described with LDB-1 protein.

These novel PD-L1 PTMs and their related regulatory actions might be valuable information in the future for the design of drug strategies targeting PD-L1/PD-1 immune checkpoint inhibition.

 

PTM enrichement tools used in this citation (a.k.a. Signal-Seeker™ assays by Cytoskeleton Inc.):

  • Signal-Seeker™ Phosphotyrosine Enrichment Kit (Cat. nr 027BK160 – Cytoskeleton Inc.)
  • Signal-Seeker™ Ubiquitination Enrichment Kit (Cat. nr 027BK161 – Cytoskeleton Inc.)
  • Signal-Seeker™ SUMOylation 2/3 Enrichment Kit (Cat. nr 027BK162 – Cytoskeleton Inc.)
  • Acetyl Lysine Antibody Mouse Monoclonal (Cat. nr 027AAC01)
  • Rac/Cdc42 Activator II (Cat. nr 027CN02)

Related products:

PD-1 Cell Line to screen for activators or inhibitors of PD-1 signaling in a cellular context and characterize the biological activity of PD-1 and its interactions with ligands. PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line (Cat. nr 14960535).

PD-1 Cell Line to screen for activators or inhibitors of PD-1 signaling in a cellular context and characterize the biological activity of PD-1 and its interactions with ligands. PD-1 / NFAT Reporter – Jurkat Recombinant Cell Line (Cat. nr 14960535).

Antibodies

  • Anti-alpha/beta tubulin: sheep polyclonal (Cat. nr 027ATN02 – Cytoskeleton Inc.)
  • Anti-PD-1 Neutralizing Antibody, PE-labeled (Cat. nr 14971290-1 – Cytoskeleton Inc.)
  • Anti-PD-1 Neutralizing Antibody (Cat. nr 14971120 – BPS Bioscience)
  • Anti-PD-1 Neutralizing Antibody, Biotin-labeled (Cat. nr 14971215 – BPS Bioscience)
  • Anti-PD-1 Neutralizing Antibody, PE-labeled (Cat. nr 14971290-2 – BPS Bioscience)

Cell-based Assays

  • PD-1:PD-L1 Homogeneous Assay Kit (Cat. nr 14972014 – BPS Bioscience)
  • PD-1:PD-L1[Biotinylated] Inhibitor Screening Assay Kit (Cat. nr 14972003 – BPS Bioscience)
  • PD-1[Biotinylated]:PD-L1 Homogeneous Assay Kit (Cat. nr 14972028 – BPS Bioscience)
  • PD-1[Biotinylated]:PD-L1 Inhibitor Screening Assay Kit (Cat. nr 14972005 – BPS Bioscience)
  • PD-1[Biotinylated]:PD-L1 Inhibitor Screening Colorimetric Assay Kit (Cat. nr 14972018 – BPS Bioscience)

Source:
Horita H et al. “Identifying regulatory Posttranslational moditifcations of PD-L1: A focus on monoubiquitination (2017) Vol. 19, pp. 346-353.

Subscribe to e-Newsletters on your favourite topics
Interested in learning more about tools like this?

Subscribe to thematic newsletters on your favourite research topics. 
Philippe Fixe, PhD
Written by Philippe Fixe, PhD
Philippe Fixe is Marketing Director at tebu-bio, passionate about innovation and R&D in Life sciences, Biotechnology, Medical research, Drug discovery, and also a keen photographer.